SCHEMBL3519481

SCHEMBL3519481

CCOC(=O)c1c(O)c2cc(-c3ccccc3)cnc2n(O)c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.51
ALDH1A1 P00352 11/20 0.49
RECQL P46063 1/20 0.49
MAPT P10636 4/20 0.46
LMNA P02545 5/20 0.45
SMN1; SMN2 Q16637 5/20 0.44
GAA P10253 4/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
HTT P42858 1/20 0.43
HPGD P15428 4/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TSHR P16473 1/20 0.42
MAPK10 P53779 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3518359 0.97 KDM4E (0.48) KDM4EALDH1A1RECQLMAPTLMNA
SCHEMBL3519310 0.91 KDM4E (0.44) KDM4EALDH1A1RECQLMAPTLMNA
SCHEMBL3514731 0.90 KDM5A (0.43) KDM4EALDH1A1RECQLMAPTLMNA
SCHEMBL3516274 0.88 ALDH1A1 (0.45) KDM4EALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL3517668 0.88 KDM4E (0.48) KDM4EALDH1A1RECQLMAPTHPGD
SCHEMBL3517888 0.88 ALDH1A1 (0.42) KDM4EALDH1A1RECQLLMNASMN1; SMN2
SCHEMBL3516008 0.86 EGLN1 (0.42) KDM4EALDH1A1RECQLSMN1; SMN2HPGD
SCHEMBL3518509 0.86 KDM4E (0.50) KDM4EALDH1A1RECQLMAPTLMNA
SCHEMBL3516004 0.86 ALOX5 (0.48) KDM4EALDH1A1RECQLLMNATSHR
SCHEMBL1523339 0.85 KDM4E (0.53) KDM4EALDH1A1RECQLMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
WO-2008010964-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK & CO., INC. (US) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL KDM4E 2380/4885ALDH1A1 1486/4885RECQL 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.